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Wotiz named Cancer Center director; 
foresees expansion of its size, mission 
H e r b e r t H . W o t i z , P h . D . , w h o 
h e l p e d to p l a n the H u b e r t H . H u m -
p h r e y Cancer Research Center a n d 
has h e l d several k e y p o s i t i o n s 
w i t h i n the o r g a n i z a t i o n , has been 
n a m e d the Center ' s d i rec tor . 
The a p p o i n t m e n t was a n n o u n c e d 
b y John I . Sandson, M . D . , dean of 
Boston U n i v e r s i t y School of M e d i -
cine. I t w a s a p p r o v e d b y the Bos ton 
U n i v e r s i t y Bo ar d of Trustees o n 
June 13. 
" D r . H e r b e r t W o t i z is one of the 
o u t s t a n d i n g scientists i n the f i e l d of 
cancer research , " said Sandson, 
w h o also serves as the Cancer C e n -
ter's p r e s i d e n t . " W e are v e r y f o r t u -
nate to have D r . W o t i z as d i rec tor 
of the H u b e r t H . H u m p h r e y Cancer 
Research Center . I a m cer ta in he 
w i l l p r o v i d e the l eadersh ip to keep 
the Cancer Research Center at the 
f o r e f r o n t of research i n th i s i m p o r -
tant f i e l d . " 
W o t i z succeeds Paul H . Black, 
M . D . , w h o became direc tor i n 1979. 
Black gave u p the p o s i t i o n i n order 
to devote m o r e t i m e to h is research 
a n d to his w o r k as c h a i r m a n of 
B U S M ' s D e p a r t m e n t of M i c r o b i o l -
o g y . " W e great ly appreciate the ex-
cel lent c o n t r i b u t i o n s tha t D r . Black 
has m a d e to the Cancer Center over 
the last f ive y e a r s , " Sandson said. 
W o t i z said the p r i n c i p a l chal lenge 
i n the next f e w years is to e x p a n d 
the Center care fu l ly a n d del iberate ly , 
m a k i n g sure n o t to j eopard ize the 
sense of m i s s i o n a n d the cohesive-
ness tha t have m a r k e d the Center 's 
o p e r a t i o n i n the past . 
" R i g h t n o w , m o s t of o u r w o r k is 
concentra ted i n the areas of cell b i -
o l o g y , i m m u n o r e g u l a t i o n a n d t o x i -
c o l o g y , " he n o t e d . " W e m u s t con-
t i n u e to foster creative w o r k i n 
those areas, b u t at the same t i m e be 
p r e p a r e d to encourage e x p a n s i o n i n 
o ther f ie lds tha t log ica l ly f i t i n w i t h 
the overa l l m i s s i o n of the C e n t e r . " 
W o t i z said he is especially eager 
to p r o m o t e e x p a n s i o n of the Cen-
ter's c l in ica l research p r o g r a m . The 
n e w direc tor also said the Center 
m u s t c o n t i n u e to g r o w i n a p h y s i c a l 
sense. " I t is v e r y u s e f u l to have a 
f loor tha t be longs to the Cancer 
Center i n the n e w Centers for A d -
v a n c e m e n t i n H e a l t h a n d M e d i c i n e 
b u i l d i n g , " said W o t i z . " H o w e v e r , 
w e are g o i n g to have a c o n t i n u i n g 
need for m o r e space, a n d m e e t i n g 
that n e e d w i l l be one of m y goals as 
d irec tor . I h o p e w e w i l l have the 
equiva lent of t w o or three m o r e 
f loors w i t h i n the next f e w y e a r s . " 
The n e w Center d i rec tor also said 
he hopes to take advantage of the 
p o s i t i o n to h e l p emphas ize the i m -
portance of cancer p r e v e n t i o n . 
" M u c h of cancer is a v o l u n t a r y dis -
ease," said W o t i z . " I f s m o k i n g w e r e 
e l i m i n a t e d , w e c o u l d reduce the 
rate of l u n g cancer i n th is c o u n t r y 
to a f e w percent of w h a t i t is t o d a y . 
Changes i n the n a t i o n ' s d ie t , w i t h 
an increased emphas is o n f i b r o u s 
a n d n o n - f a t t y foods , also w o u l d 
m a k e a d i f ference . So I p l a n to d o 
w h a t I can to d r a w a t t e n t i o n to the 
continued on page 5 
Probing the links between hormones, cancer 
H o r m o n e s are, i n effect, the W e s t e r n U n i o n br igade of the h u m a n 
b o d y . 
T h e y course t h r o u g h the b l o o d s t r e a m , d e l i v e r i n g a host of d i f f e r e n t 
messages: Store u p energy-bear ing sugars! (a c o m m a n d d e l i v e r e d b y 
the f a m i l i a r h o r m o n e k n o w n as i n s u l i n ) ; Get ready to f i g h t or flee! 
( e p i n e p h r i n e a n d n o r e p i n e p h r i n e ) ; Excrete m o r e l i q u i d s ! (vasopres-
sin) ; a n d so o n . 
C o n s i d e r i n g the i r i m p o r t a n c e i n r e g u l a t i n g p h y s i o l o g i c a l act ivi t ies , 
i n c l u d i n g cell g r o w t h , h o r m o n e s are a logical focus for cancer i n v e s t i -
gators . Cancer, after a l l , is n o m o r e t h a n cell g r o w t h r u n a m o k . 
There s t i l l is m u c h to be l earned , h o w e v e r , about the re la t ionships 
b e t w e e n h o r m o n e s a n d cancer. The s tory of h o w some m e m b e r s of 
the H u m p h r e y Cancer Research Center are h e l p i n g to increase the 
u n d e r s t a n d i n g of such re la t ionsh ips begins o n page 3. 
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F R O M T H E D I R E C T O R 
Dear Fr iends , 
A cancer center m u s t be responsive 
to w h a t is h a p p e n i n g outs ide its 
w a l l s . I n p a r t i c u l a r , i t m u s t reflect 
the w a y s i n w h i c h the e f for t to con-
t r o l cancer is e v o l v i n g . Since I was 
h o n o r e d b y b e i n g n a m e d direc tor of 
the H u b e r t H . H u m p h r e y Cancer 
Research Center , I have been g i v i n g 
th i s subject a great deal of t h o u g h t . 
I n the course of m y l o n g i n v o l v e -
m e n t w i t h cancer research, I have 
w i t n e s s e d considerable progress i n 
the f i e l d . I v i e w this progress as 
t a k i n g the f o r m of t w o large, in ter -
connected w a v e s . 
O n e w a v e represents advances i n 
t h e r a p y , w h i c h have been q u i t e sig-
n i f i c a n t . Cerv ica l cancer, for exam-
p l e , n o w has a v e r y h i g h rate of 
cure as the resul t of d e v e l o p m e n t of 
the Pap smear for early d iagnos is . 
Some f o r m s of l e u k e m i a also are 
h i g h l y respons ive to t r e a t m e n t , a n d 
there has been m e a n i n g f u l progress 
against o ther types of cancer as 
w e l l . There are some types of can-
cer, h o w e v e r , i n w h i c h progress has 
been m o d e s t . Those of us w h o are 
i n v o l v e d i n cancer research are 
d e e p l y aware of the l i m i t e d p r o g -
ress i n u n d e r s t a n d i n g a n d t r e a t i n g 
m a n y f o r m s of cancer, a n d apprec i -
ate w h y the p u b l i c m a y feel some 
d i s e n c h a n t m e n t w i t h the e f for t to 
eradicate the disease. 
The second w a v e is m a d e u p of 
the basic research f i n d i n g s re la ted 
to cancer. H e r e , a n inves t iga tor 
m u s t choose his w o r d s w i t h cau-
t i o n . E n t h u s i a s m a b o u t basic re-
search advances is o f t e n m i s c o n -
s t r u e d b y the p u b l i c as evidence 
th a t v i c t o r y over cancer of a l l types 
is near. I t is clear to m e , h o w e v e r , 
th a t the a c c u m u l a t i o n o f basic 
k n o w l e d g e a b o u t cancer has 
reached r e m a r k a b l e p r o p o r t i o n s . W e 
are b e g i n n i n g to u n d e r s t a n d some 
of the f u n d a m e n t a l s of cell g r o w t h 
a n d cell r e g u l a t i o n . Th is k n o w l e d g e 
w i l l n o t lead to i n s t a n t a n d m a r k e d 
i m p r o v e m e n t s i n cancer t h e r a p y . 
There s t i l l is a great deal to be 
l e a r n e d , a n d there are m a n y h u r -
dles to be o v e r c o m e before some of 
the m o s t recent a n d exc i t ing f i n d -
ings of the basic research labora tory 
can be t rans la ted i n t o m a j o r n e w 
m e t h o d s of d iagnos is a n d treat-
m e n t . Never the less , the progress is 
real , a n d I a m c o n v i n c e d i t w i l l be-
g i n to have a m a j o r i m p a c t o n can-
cer t r e a t m e n t w e l l before the e n d of 
th is c e n t u r y , a n d poss ib ly w i t h i n 
the c u r r e n t decade. 
The a c c u m u l a t i o n of k n o w l e d g e 
about f u n d a m e n t a l aspects of cancer 
gives a d d e d i m p o r t a n c e to the role 
of cancer centers. For one t h i n g , i t 
is increas ing ly d i f f i c u l t fo r inves t iga-
tors to keep u p w i t h the f i n d i n g s i n 
the i r o w n specialit ies, m u c h less 
cancer research as a w h o l e . A t the 
same t i m e , the g r o w t h of k n o w l -
edge makes i t clear that w e can n o 
longer d r a w precise d i s t i n c t i o n s 
a m o n g d i f f e r e n t areas of specializa-
t i o n . A t o u r o w n Center , for exam-
p l e , w e have toxicologists w h o are 
d e e p l y concerned w i t h the effects of 
carcinogens o n D N A . This means 
t h e y m u s t w o r k closely w i t h molec-
u lar b io logis ts w h o are expert i n the 
s t ruc ture a n d f u n c t i o n s of D N A . 
L i k e w i s e , w e have i m m u n o l o g i s t s 
w h o are d e v e l o p i n g the n e w , c o m -
plex cells k n o w n as h y b r i d o m a s for 
use i n cancer research a n d t h e r a p y . 
These inves t igators are w o r k i n g 
closely w i t h cell b io logis ts . 
The g r o w t h of k n o w l e d g e , a n d 
the f a d i n g of l ines b e t w e e n special-
ties, m e a n tha t the Cancer Center 's 
t r a d i t i o n a l role of f o s t e r i n g coopera-
t i o n across d i s c i p l i n a r y l ines is m o r e 
s igni f i cant t h a n ever. I t is n o longer 
realistic for a n y one l i n e of research 
to s tand alone. Inves t igators m u s t 
p o o l t h e i r ski l ls a n d the i r k n o w l -
edge, or the rate at w h i c h k n o w l -
edge cont inues to m o u n t w i l l be 
s h a r p l y c u r t a i l e d . 
Regards, 
Family members at the unveiling of 
the portrait of the late Sidney R. 
Cooperband, M.D., that was commis-
sioned by the Humphrey Cancer Re-
search Center. Cooperband was the 
first director of the Center. Shown are 
(from left) Adele Cooperband of 
Quincy, Mass., the former director's 
mother; Selma Cooperband of Milton, 
Mass., widow of Sidney Cooperband; 
and Robert Cooperband, also of Mil-
ton, the former director's son. The un-
veiling ceremony was held April 26, 
coinciding with this year's Cooperband 
Symposium. (The symposia are held 
annually to give members of the Can-
cer Center staff and other investiga-
tors the opportunity to report on as-
pects of their current research.) 
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Hormone receptors: 
Exploring ways to expand their usefulness 
in choosing therapies for cancer patients 
O n e centra l t h e m e stands o u t i n the 
v a r i o u s Cancer Center s tudies of the 
role of the b o d y ' s h o r m o n a l sys tem 
i n cancer: a focus o n the n a t u r e a n d 
f u n c t i o n of the substances k n o w n as 
h o r m o n e receptors . 
These chemicals b i n d the i r p a r t -
ner h o r m o n e s to the cells. W i t h o u t 
these receptors some h o r m o n e s 
w o u l d s i m p l y pass t h r o u g h the cell , 
m a k i n g n o i m p a c t o n its opera t ions . 
Receptors are concentra ted i n or 
o n those cells w h o s e f u n c t i o n s are 
m o s t affected b y the re levant h o r -
m o n e s . T h u s , receptors for the fe-
male h o r m o n e s cal led estrogens are 
f o u n d m a i n l y i n organs l i k e the 
breast a n d the u t e r u s . 
A t the Cancer Center , a ma j or re-
search g r o u p is e x p l o r i n g v a r i o u s 
aspects of the in terac t ions b e t w e e n 
receptors a n d t u m o r s u n d e r the 
l eadersh ip of Center Di re c tor H e r -
bert H . W o t i z , P h . D . , w h o heads a 
large p r o g r a m pro jec t g r a n t f r o m 
the N a t i o n a l Cancer I n s t i t u t e . Some 
of the inves t igators are seeking n e w 
w a y s to m a k e use of receptors i n 
c h o o s i n g the a p p r o p r i a t e therapies 
for cancer pa t ients . O t h e r s are ex-
p l o r i n g basic aspects of h o w h o r -
m o n e s a n d receptors affect cell 
g r o w t h , w i t h the h o p e tha t the re-
search w i l l y i e l d i n s i g h t s i n t o the 
o r ig ins of u n c o n t r o l l e d g r o w t h . 
Search for 'missing link' in 
breast-cancer prognosis 
O n e of the d i v i d e n d s of the re-
search i n t o the role of receptors i n 
t u m o r g r o w t h has been d e v e l o p -
m e n t of a n e w tech ni q ue for thera-
peut i c select ion i n breast cancer. 
Studies i n the '50s a n d '60s b y El -
w o o d V . Jensen, P h . D . , a professor 
of b i o c h e m i s t r y at the U n i v e r s i t y of 
Chicago ( a n d a rec ip ient of a 1983 
H u b e r t H . H u m p h r e y Cancer Re-
search Center A w a r d ) , f i r s t revealed 
tha t receptors can be used to m a k e 
prognoses i n breast-cancer cases. 
A c c o r d i n g to E n z i o M i i l l e r , P h . D . , 
an associate professor of b iochemis -
t r y , the t echnique consists of mea-
s u r i n g the tissue concentra t ions of 
es trogen a n d proges terone receptors 
i n breast-cancer b iopsies . Its a i m is 
to detect w h i c h t u m o r s are s t i m u -
la ted b y estrogens. 
" W e can analyze the breast tissue 
r e m o v e d d u r i n g surgery for estro-
gen-receptor c o n t e n t , " e x p l a i n e d 
M i i l l e r . " D r . Jensen s h o w e d tha t i f 
the tissue has a h i g h receptor con-
tent , i t ' s o f t e n a s i g n tha t the t u m o r 
is e s t r o g e n - s t i m u l a t e d . T h a t means 
y o u can use ant i -estrogenic t h e r a p y 
or o ther therapies based o n r e m o v a l 
of h o r m o n e - p r o d u c i n g o r g a n s . " 
O n the o ther h a n d , said the i n -
vest igator , i f the receptor content is 
v e r y l o w , tha t means the t u m o r 
m a y n o t be d e p e n d e n t u p o n estro-
gens, b u t ins tead m a y have g a i n e d 
c o n t r o l of i ts o w n g r o w t h . Such t u -
m o r s cannot be ef fect ively treated 
t h r o u g h h o r m o n a l m a n i p u l a t i o n . 
Enzio Miiller, Ph.D., checks readings from a 
scintillation counter, used to measure tiny 
amounts of radioactivity that are deliberately 
added to cells and tissues in many types of 
basic research. (Photo by Bradford P. Herzog) 
The technique has been used as a 
g u i d e i n t r e a t i n g t h o u s a n d s of 
breast-cancer pa t ients . I t is n o t to -
ta l ly rel iable , t h o u g h . I n r o u g h l y 25 
percent of the pat ients w i t h h i g h 
levels of es trogen a n d progesterone 
receptors , the t r a d i t i o n a l t rea tments 
for e s t r o g e n - s t i m u l a t e d t u m o r s d o 
n o t w o r k . 
There are several theories to ac-
c o u n t for th is d iscrepancy, said 
M i i l l e r . " O n e is tha t the t u m o r s i n 
these pat ients are m a d e u p of d i f f e r -
ent types of cells, some estrogen-de-
p e n d e n t a n d some n o t , " he ex-
p l a i n e d . " A n o t h e r is tha t there are 
defects i n the cel lular m e c h a n i s m s 
t r i g g e r e d b y the receptors , so tha t 
e v e n t h o u g h the receptors are pres-
ent i n the t u m o r cells t h e y d o n ' t 
s t imula te t u m o r g r o w t h . " 
W h a t e v e r the cause, there s t i l l is 
a need for a test to i d e n t i f y those 
cancer pat ients w h o appear su i ted to 
ant i -es t rogen t h e r a p y b u t i n fact are 
n o t . M i i l l e r a n d his associates are 
w o r k i n g o n v a r i o u s approaches to 
r e s o l v i n g th is p r o b l e m . 
O n e of t h e i r pro jects , said M i i l l e r , 
i n v o l v e s p r o b i n g the n a t u r e of the 
estrogen receptors themselves , 
searching for w a y s to d i s t i n g u i s h 
b e t w e e n active a n d inact ive recep-
tors . O u t of th is e f for t m a y come a 
test tha t i n v o l v e s c o m b i n i n g recep-
tors w i t h estrogens, a n d t h e n m o n i -
t o r i n g h o w fast the receptors a n d 
h o r m o n e s become u n c o u p l e d . 
" I f y o u f o u n d that receptors f r o m 
some pat ients became detached 
faster t h a n receptors f r o m o t h e r s , " 
said M i i l l e r , " a n d tha t the rate of 
d e t a c h m e n t corre la ted w i t h h o w 
w e l l the pat ients r e s p o n d e d to a n t i -
es trogen t r e a t m e n t , tha t m i g h t h e l p 
y o u i d e n t i f y the receptors tha t w e r -
en ' t w o r k i n g . " 
A n o t h e r a p p r o a c h is to use the 
h o r m o n e ' s i m p a c t o n genes as a 
w a y of d i s t i n g u i s h i n g active f r o m 
inact ive receptors . There is n o real-
istic w a y to measure changes i n the 
genes themselves , n o t e d M i i l l e r , b u t 
i t m a y be possible to measure 
changes i n the p r o t e i n s generated 
b y the genes. 
" Y o u w o u l d a d d a receptor to n u -
clei f r o m t u m o r ce l l s , " said the i n -
vest igator , " a n d since y o u w o u l d 
k n o w tha t i f the receptor w e r e f u n c -
t i o n i n g cer ta in p r o t e i n s w o u l d be 
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Paul F. Pilch, Ph.D., in his office. (Photo by Joan Clifford, Educational Media, BUSM) 
expressed, th is w o u l d g ive y o u an-
o ther w a y of t e s t i n g for b io log ica l ly 
active r e c e p t o r s . " 
N e i t h e r pro jec t is l i k e l y to y i e l d a 
q u i c k s o l u t i o n to the p r o b l e m of the 
gap i n breast-cancer e v a l u a t i o n , said 
M i i l l e r . " I t w i l l be a n o t h e r f e w years 
before w e w i l l have a m e t h o d of 
s h o w i n g w h e t h e r a receptor is f u n c -
t i o n i n g or n o t , " he said, " a n d 
w h e t h e r tha t is i n d e e d re la ted to 
the t y p e of t u m o r i n v o l v e d . " 
Probing normal receptors 
for dues to tumor growth 
The last f e w years have seen the 
emergence of some remarkable n e w 
h y p o t h e s e s about the b iochemica l 
c o n d i t i o n s tha t set the stage for the 
f o r m a t i o n of t u m o r s . 
The i d e n t i f i c a t i o n of a g r o u p of 
genes t h a t are f o u n d i n viruses 
k n o w n to cause cancer i n an i mal s , 
a n d t h a t bear a close resemblance to 
cer ta in h u m a n genes, has i n s p i r e d 
h o p e t h a t i t m a y soon be possible to 
p i n p o i n t the genes that h e l p cause 
cell g r o w t h to go o u t of c o n t r o l . The 
t h e o r y is t h a t these are n o r m a l 
genes t h a t have s o m e h o w been 
s l i g h t l y a l te red , a n d hence are n o 
l o n g e r subject to the b o d y ' s n a t u r a l 
systems f o r t u r n i n g g r o w t h - r e l a t e d 
genes o n a n d off . 
The genes t h o u g h t to be i m p l i -
cated i n u n c o n t r o l l e d g r o w t h have 
been e n t i t l e d oncogenes (oncogene-
sis is the technica l t e r m for t u m o r 
d e v e l o p m e n t ) . So far, r o u g h l y 20 
oncogenes have been i d e n t i f i e d , 
m o s t l y i n cancer-causing viruses . 
A l s o s t i r r i n g intense interest is 
the f i n d i n g t h a t some of the p r o -
teins expressed b y the oncogenes 
are c losely re la ted to certa in g r o w t h 
factors a n d t h e i r receptors . ( G r o w t h 
factors are n a t u r a l substances that 
are t h o u g h t to be i n v o l v e d i n p r o -
m o t i n g cell g r o w t h . The i n t e r a c t i o n 
b e t w e e n these factors a n d the i r re-
ceptors is b e l i e v e d to be a p i v o t a l 
step i n t h e c o n t r o l of n o r m a l cell 
g r o w t h . ) 
These theor ies about cel lular c o m -
p o n e n t s t h a t m a y u n d e r l i e the 
g r o w t h of t u m o r s , w h i l e exc i t ing , 
are s t i l l far f r o m p r o v e n , according 
to Cancer Center inv es t i ga tor Paul 
F. P i l ch , P h . D . , an associate profes-
sor of b i o c h e m i s t r y . I n fact, said 
P i lch , scientists s t i l l u n d e r s t a n d 
v e r y l i t t l e about the r e g u l a t i o n of 
normal cell d i v i s i o n a n d g r o w t h . 
M u c h of the research b e i n g d o n e 
b y Pi lch a n d his associates, there-
fore , is a i m e d at f i l l i n g the vast gaps 
i n w h a t is k n o w n about n o r m a l 
g r o w t h . 
O n e p a r t i c u l a r focus , said P i lch , is 
a g r o w t h factor tha t is t h o u g h t to 
h e l p regulate b o t h e m b r y o n i c a n d 
a d u l t cell g r o w t h . I t is cal led i n s u -
l i n - l i k e g r o w t h factor 1 (IGF-1), a 
n a m e tha t reflects the fact that i t is 
chemica l ly s imi lar to i n s u l i n , a n d 
tha t there is another , s imi lar g r o w t h 
factor, IGF-2. 
" I t appears tha t the IGF-1 
s t imulates the g r o w t h of cells at n u -
m e r o u s sites t h r o u g h o u t the b o d y , " 
said P i l ch . " W e p r e s u m e tha t th is 
cont inues as l o n g as the IGF-1 is 
b e i n g p r o d u c e d a n d tha t w h e n p r o -
d u c t i o n stops, cell g r o w t h m a y stop 
as w e l l . 
" T h e e x p e r i m e n t s w e p l a n to d o 
are i n t e n d e d to d e t e r m i n e i f w e can 
detect specific changes i n the cell 
b r o u g h t a b o u t b y I G F - 1 , a n d i f w e 
can t h e n l i n k those changes to 
stages of cell g r o w t h . " 
P i lch a n d his colleagues are par-
t i c u l a r l y eager to f i n d o u t h o w IGF-
1 a n d its receptor , once t h e y l i n k 
u p , c o m m u n i c a t e to the cell nuc leus 
that the t i m e has come to start 
d i v i d i n g . 
O n e t h e o r y , said P i l ch , is tha t the 
c o m b i n e d molecules t r igger f o r m a -
t i o n of a substance tha t is k n o w n to 
act as a n in t race l lu lar messenger. 
This substance, i n o s i t o l t r i p h o s -
phate (IP3), m a y i n t u r n ei ther acti-
vate g r o w t h - r e l a t e d genes o n its 
o w n , or s t i m u l a t e o ther substances 
w i t h i n the cell to d o so. Some of the 
exper iments tha t P i lch a n d his asso-
ciates are n o w d e s i g n i n g m a y estab-
l i s h w h e t h e r tha t t h e o r y is correct. 
The f i r s t series of exper iments is 
a i m e d at f i n d i n g o u t precisely h o w 
IGF-1 affects cells. T h e n , the i n v e s t i -
gators w i l l a p p l y IP3 to s imi lar cells, 
to see i f the cells' response is the 
same as w h e n the g r o w t h factor is 
used . " I f w e can m i m i c the effects 
of the IGF-1 u s i n g i n o s i t o l t r i p h o s -
phate , tha t w o u l d t e n d to establ ish 
that IP3 is i n fact the messenger , " 
said P i l ch . 
H e a d d e d tha t recent f i n d i n g s 
that some oncogene p r o t e i n s can 
synthesize IP3 i n the test tube sug-
gest the p o s s i b i l i t y of a l i n k be-
t w e e n the substance a n d t u m o r de-
v e l o p m e n t . But i n a n y case, said 
Pi lch , c l a r i f y i n g the role of IP3 
w o u l d h e l p to f i l l i n some a d d i t i o n a l 
details i n the o v e r a l l p i c t u r e of h o w 
d i v i s i o n a n d g r o w t h are c o n t r o l l e d 
i n the n o r m a l c e l l — a n d thereby 
poss ib ly p r o v i d e some i n s i g h t i n t o 
u n c o n t r o l l e d d i v i s i o n a n d g r o w t h as 
w e l l . 
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A role for receptors in evaluating 
prostate cancer and leukemia? 
The usefulness of h o r m o n e recep-
tors i n e v a l u a t i n g d i f f e r e n t types of 
breast cancer is w e l l es tabl ished, b u t 
m i g h t receptors also p r o v e h e l p f u l 
i n e v a l u a t i n g o ther k i n d s of can-
cers? 
T h a t q u e s t i o n c u r r e n t l y is b e i n g 
p u r s u e d b y t w o Cancer Center re-
search g r o u p s . O n e , h e a d e d b y 
R o n a l d P. M c C a f f r e y , M . D . , an as-
sociate professor of m e d i c i n e , is ex-
p l o r i n g w h e t h e r receptor t es t ing can 
h e l p phys i c ians select the best ther-
apies for l e u k e m i a . A second, 
h e a d e d b y A b d u l T r a i s h , P h . D . , an 
assistant research professor of b io -
c h e m i s t r y , is s t u d y i n g w h e t h e r re-
ceptor assays can be u s e d i n choos-
i n g therapies for prostate cancer. 
A c c o r d i n g to T r a i s h , after the an-
d r o g e n tes tos terone—the male sex 
h o r m o n e — h a s been secreted b y the 
testes a n d reaches the prostate 
g l a n d , i t is c o n v e r t e d to a m o r e p o -
tent h o r m o n e cal led d i h y d r o t e s t o s -
terone . Th is n e w h o r m o n e t h e n 
b i n d s to the g land ' s a n d r o g e n re-
ceptors . 
D i h y d r o t e s t o s t e r o n e is k n o w n to 
s t i m u l a t e prostate t u m o r g r o w t h . 
There fore , u s i n g m e a s u r e m e n t s of 
its receptors for p r o g n o s t i c p u r -
poses, j u s t as es t rogen a n d proges-
terone receptor m e a s u r e m e n t s are 
u s e d i n d i s t i n g u i s h i n g a m o n g types 
of breast t u m o r s , m i g h t seem e m i -
n e n t l y logica l . The p r o b l e m , said 
T r a i s h , is tha t a n d r o g e n receptors 
are h a r d to measure . 
T r a i s h a n d his associates, t h o u g h , 
have f o u n d tha t t h e y can m a k e ac-
curate m e a s u r e m e n t s of receptors 
that are b o u n d to h o r m o n e s i n labo-
r a t o r y a n i m a l s . T h e t e c h n i q u e — 
w h i c h i n v o l v e s a sophis t ica ted use 
of h o r m o n e s c o n t a i n i n g radioac t iv -
i t y — a l l o w s the inves t igators to c o m -
pare those m e a s u r e m e n t s w i t h re-
ceptor levels i n tissues r e m o v e d 
f r o m the b o d y . T h u s , t h e y can i d e n -
t i f y u n d e r w h a t c o n d i t i o n s receptors 
m a y be m a i n t a i n e d at stable levels 
after tissues are r e m o v e d . 
" N o w w e w a n t to t r y to a p p l y 
these f i n d i n g s to tissues r e m o v e d 
d u r i n g s u r g e r y i n v o l v i n g prostat ic 
cancer p a t i e n t s , " said T r a i s h , " a n d 
to see i f w e can correlate the pa-
t ients ' responses to t h e i r receptor 
l e v e l s . " 
The t e c h n i q u e , i f i t w o r k s o u t , 
c o u l d be of great v a l u e to prostate-
cancer pat ients . T r e a t m e n t s for this 
t y p e of cancer, said T r a i s h , o f t e n i n -
v o l v e t r y i n g to keep the pat ient ' s 
h o r m o n e s f r o m s t i m u l a t i n g f u r t h e r 
t u m o r g r o w t h . B u t w h i l e the thera-
pies seem to w o r k at the outset i n 
r o u g h l y three-quarters of a l l pa-
t ients a f fected, t h e y are effect ive for 
o n l y a f e w m o n t h s i n half tha t 
g r o u p . 
A receptor assay, said T r a i s h , 
c o u l d h e l p doctors p r e d i c t w h i c h 
pat ients m i g h t r e s p o n d over the 
l o n g t e r m to h o r m o n a l m a n i p u l a -
t i o n , a n d w h i c h m i g h t benef i t m o r e 
f r o m other types of therapies . 
I n l e u k e m i a , there is a discrep-
ancy b e t w e e n the presence of recep-
tors for a g r o u p of h o r m o n e s called 
g lucocor t i co ids i n cancerous cells, 
a n d the response of l e u k e m i a pa-
t ients to t r e a t m e n t w i t h these h o r -
m o n e s . 
" I n the 1950s a n d 1960s, m a n y 
l eukemias w e r e t reated solely b y ad-
m i n i s t e r i n g g l u c o c o r t i c o i d s , " said 
M c C a f f r e y . " T h e experience f r o m 
that m o d e of t r e a t m e n t s h o w e d that 
o n l y a b o u t 60 percent of the pa-
t ients r e s p o n d e d to the t r e a t m e n t . 
Yet v i r t u a l l y a l l l e u k e m i c cells con-
t a i n g l u c o c o r t i c o i d receptor m a t e r i a l . 
The p r e d i c t i o n f r o m tha t f i n d i n g is 
that a l l such pat ients s h o u l d re-
s p o n d to g l u c o c o r t i c o i d t h e r a p y . " 
M c C a f f r e y a n d his associates, 
h o w e v e r , have d i scovered t h r o u g h 
a series of m o r e sophis t i ca ted tests 
that some l e u k e m i c cells have ab-
n o r m a l receptors . " I t looks l ike a 
n o r m a l r e c e p t o r , " he e x p l a i n e d , 
" a n d i t b i n d s the g lucocor t i co ids , 
b u t i n o ther w a y s i t doesn ' t act l ike 
a n o r m a l r e c e p t o r . " 
C u r r e n t l y u n d e r s t u d y is w h e t h e r 
the presence of th is a b n o r m a l h o r -
m o n e receptor means tha t glucocor-
t icoids are u n l i k e l y to be of h e l p i n 
c o m b a t i n g tha t t y p e of l e u k e m i a , 
a n d tha t a l te rnat ive therapeut i c ap-
proaches s h o u l d be p u r s u e d . 
Ronald P. McCaffrey, M.D. 
Director . . . 
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t h i n g s t h a t the average p e r s o n can 
d o to reduce the cancer rates i n th is 
c o u n t r y . " 
W o t i z , w h o received his doctorate 
i n c h e m i s t r y f r o m Yale U n i v e r s i t y , 
j o i n e d the B U S M facu l ty i n 1950. H e 
was i m m e d i a t e l y assigned to set u p 
the School's f i r s t cancer research 
l a b o r a t o r y , a n d has been i n v o l v e d 
i n cancer research ever since. 
W o t i z cha i red the s u b c o m m i t t e e 
w h i c h w a s establ ished i n the ear ly 
1970s to p l a n a cancer center at Bos-
t o n U n i v e r s i t y School of M e d i c i n e . 
A f t e r S idney C o o p e r b a n d , M . D . , a 
persona l f r i e n d of W o t i z ' , was se-
lected as the Center ' s f i r s t d i rec tor , 
W o t i z agreed to serve as associate 
direc tor of the o r g a n i z a t i o n . 
The n e w direc tor has c o n t i n u e d 
to p l a y a n active role i n the Cancer 
Center since t h e n . 
A na t ive of V i e n n a , A u s t r i a , 
W o t i z l ives i n M i l t o n , Mass . H i s 
w i f e , M i r i a m , is a w e l l - k n o w n 
p a i n t e r of N e w E n g l a n d scenes. The 
couple has three g r o w n c h i l d r e n : 
Sue W . G o l d s t e i n , Robert P. a n d 
R i c h a r d A . 
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New Center members 
T w o n e w m e m b e r s f r o m outs ide the 
Bos ton U n i v e r s i t y M e d i c a l Center 
c o m m u n i t y have j o i n e d the H u m -
p h r e y Cancer Center i n recent 
m o n t h s . T h e y are: 
• John R. M u r p h y , P h . D . , research 
professor of b i o c h e m i s t r y a n d re-
search professor of m e d i c i n e . M u r -
p h y came f r o m H a r v a r d M e d i c a l 
School , w h e r e he w a s a n associate 
professor i n the D e p a r t m e n t of M i -
c r o b i o l o g y a n d M o l e c u l a r Cenetics . 
H e also w a s Eawrence J. H e n d e r s o n 
Associate Professor of H e a l t h Sci-
ences a n d T e c h n o l o g y i n the H a r -
v a r d - M I T P r o g r a m i n H e a l t h Sci-
ences, T e c h n o l o g y a n d 
M a n a g e m e n t . The n e w Cancer Cen-
ter m e m b e r is a graduate of the 
U n i v e r s i t y of C o n n e c t i c u t , a n d re-
ceived his doctorate f r o m the U n i -
v e r s i t y of C o n n e c t i c u t School of 
M e d i c i n e . H i s chief research interest 
is d e v e l o p i n g m o d e l systems for de-
l i v e r i n g a l tered d i p h t h e r i a t o x i n to 
cancerous cells. ( A p r o f i l e of M u r -
p h y w i l l appear i n a f u t u r e issue of 
the Humphrey Report.) 
• Patricia E. Eoster, P h . D . , assistant 
professor of p u b l i c h e a l t h ( e n v i r o n -
m e n t a l h e a l t h ) , Bos ton U n i v e r s i t y 
School of Publ ic H e a l t h . Pr ior to 
c o m i n g to Bos ton U n i v e r s i t y M e d i -
cal Center , Eoster was a f e l l o w i n 
the D e p a r t m e n t of Cancer B i o l o g y 
at H a r v a r d School of Publ ic H e a l t h . 
She is a graduate of the U n i v e r s i t y 
of Chicago , a n d rece ived her docto-
rate i n a p p l i e d b i o l o g y f r o m C a m -
b r i d g e U n i v e r s i t y , C a m b r i d g e , En-
g l a n d . Eoster's p r i m a r y research 
interest is i n v e s t i g a t i n g the w a y i n 
w h i c h v a r i o u s carcinogens cause 
m u t a t i o n s i n cells. 
Equipment donated 
A i d for Cancer Research, a v o l u n -
teer o r g a n i z a t i o n , has d o n a t e d t w o 
pieces of e q u i p m e n t w i t h a c o m -
b i n e d va lue of m o r e t h a n $10,000 to 
the l a b o r a t o r y of Cancer Center 
m e m b e r H e r b e r t Z . K u p c h i k , P h . D . , 
associate professor of m i c r o b i o l o g y 
a n d p a t h o l o g y . 
D o n a t e d w e r e a l a m i n a r f l o w 
h o o d , u s e d to m a i n t a i n a sterile en-
v i r o n m e n t for e x p e r i m e n t s i n v o l v -
i n g t u m o r cells, a n d a carbon d i o x -
ide i n c u b a t o r , i n w h i c h cells can be 
m a i n t a i n e d at a constant t e m p e r a -
t u r e a n d h u m i d i t y . 
O n h a n d for the p r e s e n t a t i o n cer-
e m o n y for the e q u i p m e n t , h e l d i n 
M a y , w e r e several A C R m e m b e r s , 
as w e l l as K u p c h i k a n d Cancer C e n -
ter Di re c tor H e r b e r t H . W o t i z , 
P h . D . 
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Leah Lowenstein, M.D., 
1930-1984 
Eeah M . E o w e n s f e i n , M . D . , D . 
P h i l . , a f o r m e r m e m b e r of the 
Cancer Center a n d a f o r m e r 
professor a n d associate d ea n of 
Bos ton U n i v e r s i t y School of 
M e d i c i n e , d i e d M a r c h 6 of can-
cer. She was 53. 
The last p o s i t i o n E o w e n s t e i n 
h e l d p r i o r to her d e a t h w a s 
d e a n a n d vice p r e s i d e n t of the 
Jefferson M e d i c a l College of 
T h o m a s Jefferson U n i v e r s i t y i n 
P h i l a d e l p h i a . 
E o w e n s t e i n ' s research focus 
was k i d n e y disease. She con-
d u c t e d studies of the regenera-
t i o n of k i d n e y tissue f o l l o w i n g 
i n j u r y or rena l f a i l u r e , a n d of 
the m e t a b o l i s m of a m i n o acids. 
O n e of o n l y three w o m e n i n 
her class at the U n i v e r s i t y of 
W i s c o n s i n School of M e d i c i n e , 
E o w e n s t e i n w a s a s t r o n g a d v o -
cate of o p e n i n g u p the m e d i c a l 
pro fess ion to w o m e n . W i t h her 
a p p o i n t m e n t at Jefferson, she 
became the f i rs t w o m a n dean 
of a coeducat iona l m e d i c a l 
school i n the n a t i o n ' s h i s t o r y . 
"She was one of the o u t -
s t a n d i n g leaders i n the m e d i c a l 
f i e l d i n the last 10 y e a r s , " said 
B U S M D e a n John I . Sandson, 
M . D . " D r . E o w e n s t e i n m a d e 
m a j o r c o n t r i b u t i o n s i n science, 
teaching , a d m i n i s t r a t i o n a n d 
c l inical care, a n d d i d a great 
deal to advance the role of 
w o m e n i n m e d i c i n e . " 
E o w e n s t e i n is s u r v i v e d b y 
her h u s b a n d , John, a professor 
of b i o c h e m i s t r y at Brandeis 
U n i v e r s i t y ; a n d sons Charles , 
A n d r e w a n d M a r c . 
